Biocure Technology Inc.
CUREX
CNSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 4,500.00% | -99.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4,500.00% | -99.93% | |||
| Operating Income | -4,500.00% | 99.93% | |||
| Income Before Tax | -252.27% | 97.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -252.27% | 97.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -252.27% | 97.06% | |||
| EBIT | -4,500.00% | 99.93% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -225.00% | 96.67% | |||
| Normalized Basic EPS | -166.67% | 96.00% | |||
| EPS Diluted | -225.00% | 96.67% | |||
| Normalized Diluted EPS | -166.67% | 96.00% | |||
| Average Basic Shares Outstanding | 16.31% | -16.01% | |||
| Average Diluted Shares Outstanding | 16.31% | -16.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||